Amedisys Statistics
Total Valuation
Amedisys has a market cap or net worth of $3.09 billion. The enterprise value is $3.45 billion.
Market Cap | 3.09B |
Enterprise Value | 3.45B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
Earnings Date | Apr 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Amedisys has 32.68 million shares outstanding. The number of shares has increased by 1.03% in one year.
Shares Outstanding | 32.68M |
Shares Change (YoY) | +1.03% |
Shares Change (QoQ) | +1.05% |
Owned by Insiders (%) | 2.30% |
Owned by Institutions (%) | 93.27% |
Float | 32.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 20.13 |
PS Ratio | 1.37 |
Forward PS | 1.28 |
PB Ratio | 2.84 |
P/FCF Ratio | 31.52 |
PEG Ratio | 1.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.04, with an EV/FCF ratio of 35.21.
EV / Earnings | n/a |
EV / Sales | 1.53 |
EV / EBITDA | 28.04 |
EV / EBIT | 53.29 |
EV / FCF | 35.21 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.44.
Current Ratio | 1.09 |
Quick Ratio | 0.99 |
Debt / Equity | 0.44 |
Debt / EBITDA | 3.92 |
Debt / FCF | 4.92 |
Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is -2.00% and return on invested capital (ROIC) is -5.82%.
Return on Equity (ROE) | -2.00% |
Return on Assets (ROA) | -1.00% |
Return on Capital (ROIC) | -5.82% |
Revenue Per Employee | $118,495 |
Profits Per Employee | -$1,084 |
Employee Count | 19,000 |
Asset Turnover | 1.10 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Amedisys has paid $53.39 million in taxes.
Income Tax | 53.39M |
Effective Tax Rate | 162.79% |
Stock Price Statistics
The stock price has increased by +20.59% in the last 52 weeks. The beta is 0.84, so Amedisys's price volatility has been lower than the market average.
Beta (1Y) | 0.84 |
52-Week Price Change | +20.59% |
50-Day Moving Average | 92.63 |
200-Day Moving Average | 93.30 |
Relative Strength Index (RSI) | 60.47 |
Average Volume (30 Days) | 281,276 |
Short Selling Information
The latest short interest is 2.31 million, so 7.06% of the outstanding shares have been sold short.
Short Interest | 2.31M |
Short Previous Month | 2.39M |
Short % of Shares Out | 7.06% |
Short % of Float | 7.21% |
Short Ratio (days to cover) | 11.17 |
Income Statement
In the last 12 months, Amedisys had revenue of $2.25 billion and -$20.59 million in losses. Loss per share was -$0.64.
Revenue | 2.25B |
Gross Profit | 999.37M |
Operating Income | 145.63M |
Pretax Income | 32.80M |
Net Income | -20.59M |
EBITDA | 122.91M |
EBIT | 64.68M |
Loss Per Share | -$0.64 |
Balance Sheet
The company has $120.70 million in cash and $481.82 million in debt, giving a net cash position of -$361.11 million or -$11.05 per share.
Cash & Cash Equivalents | 120.70M |
Total Debt | 481.82M |
Net Cash | -361.11M |
Net Cash Per Share | -$11.05 |
Equity / Book Value | 1.09B |
Book Value Per Share | 33.30 |
Working Capital | 41.59M |
Cash Flow
In the last 12 months, operating cash flow was $104.69 million and capital expenditures -$6.80 million, giving a free cash flow of $97.88 million.
Operating Cash Flow | 104.69M |
Capital Expenditures | -6.80M |
Free Cash Flow | 97.88M |
FCF Per Share | $3.00 |
Margins
Gross margin is 44.39%, with operating and profit margins of 6.47% and -0.91%.
Gross Margin | 44.39% |
Operating Margin | 6.47% |
Pretax Margin | 1.46% |
Profit Margin | -0.91% |
EBITDA Margin | 5.46% |
EBIT Margin | 2.87% |
FCF Margin | 4.35% |
Dividends & Yields
Amedisys does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.03% |
Shareholder Yield | -1.03% |
Earnings Yield | -0.67% |
FCF Yield | 3.17% |
Analyst Forecast
The average price target for Amedisys is $100.83, which is 6.78% higher than the current price. The consensus rating is "Hold".
Price Target | $100.83 |
Price Target Difference | 6.78% |
Analyst Consensus | Hold |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 5, 2006. It was a forward split with a ratio of 4:3.
Last Split Date | Dec 5, 2006 |
Split Type | Forward |
Split Ratio | 4:3 |
Scores
Amedisys has an Altman Z-Score of 3.67 and a Piotroski F-Score of 4.
Altman Z-Score | 3.67 |
Piotroski F-Score | 4 |